—UTC,1:14 PM
0 M

PRE SEED ROUND

0

Subscribers in first 5 months

0

Clinic partners

AI Workflow Analysis

Retiny

We redesigned the ophthalmology screening workflow and deployed AI systems that interpret retinal imaging, prioritize urgent cases, and automate clinical follow-up.

Year

2026

Industry

Healthcare & Medical Technology

SERVICE USED

AI Workflow Analysis, AI Workflow Automation, Augmented Reality Disease Detection

Challenge

Screening volume grew faster than the capacity to interpret and act on it.

(BP® — the problem)

Retinal pathology progresses silently while imaging, documentation, and scheduling live in separate systems. Interpretation depended on specialist availability, prioritization was manual, and patients dropped out of monitoring pathways before follow-up ever happened.

(BP® — solution)

Turning imaging into clinical action, not into more data


In ophthalmology, the bottleneck is rarely the photograph. It is everything that happens after it: who reads it, how urgency is decided, and whether the patient ever returns. Each step depends on a person holding context, and none of them scale with imaging volume.

The answer was not another tool in the stack, but a redesign of the pathway between capture and care.
Instead of isolated steps, the workflow was structured as a continuous system where images, clinical notes, risk scoring, and scheduling are connected. AI operates inside the execution layer — analyzing fundus and OCT images, flagging lesion patterns, and producing structured documentation while the clinician stays focused on the exam.

An augmented reality layer brings detection into the examination itself, overlaying identified lesion patterns and confidence levels directly onto the retinal view, so findings are read in context rather than in a separate report.

In practice, the platform was built around a few core principles:

  • continuous data flow from capture to consultation

  • risk scoring embedded directly inside the clinical workflow

  • automated documentation and follow-up scheduling

  • transparent, physician-validated system behavior

A central design decision was assistance, not replacement. The system surfaces patterns and prioritizes cases, but every clinical conclusion remains with the ophthalmologist. Confidence levels are visible and the logic is auditable — a requirement for clinical trust and regulatory readiness alike.

Model development is grounded in real clinical data. Training and validation are supported by a research collaboration with the Ophthalmological Research Center at the University of Barcelona, alongside anonymized datasets from a private ophthalmology group in Argentina and a private hospital in northern Berlin, Germany.

The same architecture extends beyond the clinic. High-risk patients capture retinal images at home with a low-cost smartphone adapter; the platform compares each image against their baseline and, when deterioration is detected, alerts the physician and initiates scheduling through the clinic CRM.
Deployment fits existing environments rather than replacing them — connecting to current imaging devices and clinical systems, without a dedicated IT project.

The result is not image analysis, but a different operating model: screening produces decisions, urgency is identified automatically, and monitoring continues between visits.

(BP® — client review)

We approached it as a clinical system, not a feature. What holds up in real consultation conditions is workflow, not demos.

A man looks left

German & Zeke

Founders

0 M

PRE SEED ROUND

0

Subscribers in first 5 months

0

Clinic partners

AI Workflow Analysis

Retiny

We redesigned the ophthalmology screening workflow and deployed AI systems that interpret retinal imaging, prioritize urgent cases, and automate clinical follow-up.

Year

2026

Industry

Healthcare & Medical Technology

SERVICE USED

AI Workflow Analysis, AI Workflow Automation, Augmented Reality Disease Detection

Challenge

Screening volume grew faster than the capacity to interpret and act on it.

(BP® — the problem)

Retinal pathology progresses silently while imaging, documentation, and scheduling live in separate systems. Interpretation depended on specialist availability, prioritization was manual, and patients dropped out of monitoring pathways before follow-up ever happened.

(BP® — solution)

Turning imaging into clinical action, not into more data


In ophthalmology, the bottleneck is rarely the photograph. It is everything that happens after it: who reads it, how urgency is decided, and whether the patient ever returns. Each step depends on a person holding context, and none of them scale with imaging volume.

The answer was not another tool in the stack, but a redesign of the pathway between capture and care.
Instead of isolated steps, the workflow was structured as a continuous system where images, clinical notes, risk scoring, and scheduling are connected. AI operates inside the execution layer — analyzing fundus and OCT images, flagging lesion patterns, and producing structured documentation while the clinician stays focused on the exam.

An augmented reality layer brings detection into the examination itself, overlaying identified lesion patterns and confidence levels directly onto the retinal view, so findings are read in context rather than in a separate report.

In practice, the platform was built around a few core principles:

  • continuous data flow from capture to consultation

  • risk scoring embedded directly inside the clinical workflow

  • automated documentation and follow-up scheduling

  • transparent, physician-validated system behavior

A central design decision was assistance, not replacement. The system surfaces patterns and prioritizes cases, but every clinical conclusion remains with the ophthalmologist. Confidence levels are visible and the logic is auditable — a requirement for clinical trust and regulatory readiness alike.

Model development is grounded in real clinical data. Training and validation are supported by a research collaboration with the Ophthalmological Research Center at the University of Barcelona, alongside anonymized datasets from a private ophthalmology group in Argentina and a private hospital in northern Berlin, Germany.

The same architecture extends beyond the clinic. High-risk patients capture retinal images at home with a low-cost smartphone adapter; the platform compares each image against their baseline and, when deterioration is detected, alerts the physician and initiates scheduling through the clinic CRM.
Deployment fits existing environments rather than replacing them — connecting to current imaging devices and clinical systems, without a dedicated IT project.

The result is not image analysis, but a different operating model: screening produces decisions, urgency is identified automatically, and monitoring continues between visits.

(BP® — client review)

We approached it as a clinical system, not a feature. What holds up in real consultation conditions is workflow, not demos.

A man looks left

German & Zeke

Founders

0 M

PRE SEED ROUND

0

Subscribers in first 5 months

AI Workflow Analysis

Retiny

We redesigned the ophthalmology screening workflow and deployed AI systems that interpret retinal imaging, prioritize urgent cases, and automate clinical follow-up.

Year

2026

Industry

Healthcare & Medical Technology

SERVICE USED

AI Workflow Analysis, AI Workflow Automation, Augmented Reality Disease Detection

Challenge

Screening volume grew faster than the capacity to interpret and act on it.

(BP® — the problem)

Retinal pathology progresses silently while imaging, documentation, and scheduling live in separate systems. Interpretation depended on specialist availability, prioritization was manual, and patients dropped out of monitoring pathways before follow-up ever happened.

(BP® — solution)

Turning imaging into clinical action, not into more data


In ophthalmology, the bottleneck is rarely the photograph. It is everything that happens after it: who reads it, how urgency is decided, and whether the patient ever returns. Each step depends on a person holding context, and none of them scale with imaging volume.

The answer was not another tool in the stack, but a redesign of the pathway between capture and care.
Instead of isolated steps, the workflow was structured as a continuous system where images, clinical notes, risk scoring, and scheduling are connected. AI operates inside the execution layer — analyzing fundus and OCT images, flagging lesion patterns, and producing structured documentation while the clinician stays focused on the exam.

An augmented reality layer brings detection into the examination itself, overlaying identified lesion patterns and confidence levels directly onto the retinal view, so findings are read in context rather than in a separate report.

In practice, the platform was built around a few core principles:

  • continuous data flow from capture to consultation

  • risk scoring embedded directly inside the clinical workflow

  • automated documentation and follow-up scheduling

  • transparent, physician-validated system behavior

A central design decision was assistance, not replacement. The system surfaces patterns and prioritizes cases, but every clinical conclusion remains with the ophthalmologist. Confidence levels are visible and the logic is auditable — a requirement for clinical trust and regulatory readiness alike.

Model development is grounded in real clinical data. Training and validation are supported by a research collaboration with the Ophthalmological Research Center at the University of Barcelona, alongside anonymized datasets from a private ophthalmology group in Argentina and a private hospital in northern Berlin, Germany.

The same architecture extends beyond the clinic. High-risk patients capture retinal images at home with a low-cost smartphone adapter; the platform compares each image against their baseline and, when deterioration is detected, alerts the physician and initiates scheduling through the clinic CRM.
Deployment fits existing environments rather than replacing them — connecting to current imaging devices and clinical systems, without a dedicated IT project.

The result is not image analysis, but a different operating model: screening produces decisions, urgency is identified automatically, and monitoring continues between visits.

(BP® — client review)

We approached it as a clinical system, not a feature. What holds up in real consultation conditions is workflow, not demos.

A man looks left

German & Zeke

Founders

0 M

PRE SEED ROUND

0

Subscribers in first 5 months

0

Clinic partners

AI Workflow Analysis

Retiny

We redesigned the ophthalmology screening workflow and deployed AI systems that interpret retinal imaging, prioritize urgent cases, and automate clinical follow-up.

Year

2026

Industry

Healthcare & Medical Technology

SERVICE USED

AI Workflow Analysis, AI Workflow Automation, Augmented Reality Disease Detection

Challenge

Screening volume grew faster than the capacity to interpret and act on it.

(BP® — the problem)

Retinal pathology progresses silently while imaging, documentation, and scheduling live in separate systems. Interpretation depended on specialist availability, prioritization was manual, and patients dropped out of monitoring pathways before follow-up ever happened.

(BP® — solution)

Turning imaging into clinical action, not into more data


In ophthalmology, the bottleneck is rarely the photograph. It is everything that happens after it: who reads it, how urgency is decided, and whether the patient ever returns. Each step depends on a person holding context, and none of them scale with imaging volume.

The answer was not another tool in the stack, but a redesign of the pathway between capture and care.
Instead of isolated steps, the workflow was structured as a continuous system where images, clinical notes, risk scoring, and scheduling are connected. AI operates inside the execution layer — analyzing fundus and OCT images, flagging lesion patterns, and producing structured documentation while the clinician stays focused on the exam.

An augmented reality layer brings detection into the examination itself, overlaying identified lesion patterns and confidence levels directly onto the retinal view, so findings are read in context rather than in a separate report.

In practice, the platform was built around a few core principles:

  • continuous data flow from capture to consultation

  • risk scoring embedded directly inside the clinical workflow

  • automated documentation and follow-up scheduling

  • transparent, physician-validated system behavior

A central design decision was assistance, not replacement. The system surfaces patterns and prioritizes cases, but every clinical conclusion remains with the ophthalmologist. Confidence levels are visible and the logic is auditable — a requirement for clinical trust and regulatory readiness alike.

Model development is grounded in real clinical data. Training and validation are supported by a research collaboration with the Ophthalmological Research Center at the University of Barcelona, alongside anonymized datasets from a private ophthalmology group in Argentina and a private hospital in northern Berlin, Germany.

The same architecture extends beyond the clinic. High-risk patients capture retinal images at home with a low-cost smartphone adapter; the platform compares each image against their baseline and, when deterioration is detected, alerts the physician and initiates scheduling through the clinic CRM.
Deployment fits existing environments rather than replacing them — connecting to current imaging devices and clinical systems, without a dedicated IT project.

The result is not image analysis, but a different operating model: screening produces decisions, urgency is identified automatically, and monitoring continues between visits.

(BP® — client review)

We approached it as a clinical system, not a feature. What holds up in real consultation conditions is workflow, not demos.

A man looks left

German & Zeke

Founders

VALUES • VISION • BELIEF •VALUES • VISION • BELIEF •
VALUES • VISION • BELIEF •VALUES • VISION • BELIEF •

(qtf® — 15)

OUR PRINCIPLES

Book a
free call

We design AI systems that improve real work —
not just demonstrate technology.

We’ll review your
workflows, identify
where AI can create
impact, and outline
a clear path forward.

We’ll review your workflows, identify AI opportunities, and outline a clear path forward.

We’ll review your workflows, identify where AI can create impact, and outline
a clear path forward.

No preparation needed — we’ll guide the conversation
and focus on what matters.

No preparation needed — we’ll guide the conversation and focus on what matters.

(bp® — FINAL)

Closing Frame

Built To
Stand

AI-native companies built with engineering and
distribution that already work, from thesis to spin-out.

Home
Home
Ventures
Ventures
Articles
Articles
About us
About us
Career
Career
Contact Us
Contact Us

Socials

001.

FACEBOOK

002.

X/TWITTER

003.

LINKEDIN

004.

YOUTUBE

Legal

001.

PRIVACY POLICY

002.

LEGAL ENTITY

003.

TERMS OF SERVICE

003.

INVESTOR DISCLAIMER

BreachPoint is a European venture studio that builds AI-native companies from thesis to seed round.

BreachPoint builds AI-native companies across five verticals.

BreachPoint builds AI-native companies across five verticals.

(bp® — FINAL)

Closing Frame

Built To
Stand

AI-native companies built with engineering and
distribution that already work, from thesis to spin-out.

Home
Ventures
Articles
About us
Career
Contact Us

Socials

001.

FACEBOOK

002.

X/TWITTER

003.

LINKEDIN

004.

YOUTUBE

Legal

001.

PRIVACY POLICY

002.

LEGAL ENTITY

003.

TERMS OF SERVICE

003.

INVESTOR DISCLAIMER

BreachPoint builds AI-native companies across five verticals.